Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2005

Conditions
Hypercholesterolemia
Interventions
DRUG

Disodium Ascorbyl Phytostanol Phosphate (FM-VP4)

Trial Locations (14)

29464

Coastal Carolina Research Center, Mt. Pleasant

32114

Radiant Research, Daytona Beach

32605

Radiant Research, Gainesville

36608

Coastal Clinical Research, Mobile

46260

Midwest Institute for Clinical Research, Indianapolis

60610

Radiant Research, Chicago

64114

The Center for Pharmaceutical Research, Kansas City

66219

PRA International Pharmacology Center, Lenexa

75234

Research Across America, Dallas

75235

Radiant Research, Dallas

78758

Radiant Research, Austin

83704

Radiant Research, Boise

92123

Radiant Research, San Diego

97201

Radiant Research, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Forbes Medi-Tech

INDUSTRY

NCT00293878 - Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia | Biotech Hunter | Biotech Hunter